Associate Professor, Division of Rheumatology
University of California, Los Angeles
Los Angeles, CA, United States
Dr. Volkmann is the Director of the UCLA Scleroderma Center and the Founder and Co-Director of the UCLA Connective Tissue Disease-Related Interstitial Lung Disease (CTD-ILD) Program. Board-certified in Internal Medicine and Rheumatology, she cares for patients with systemic sclerosis and CTD-ILD. She is an active clinical and translational researcher. Her research largely focuses on understanding the cause of systemic sclerosis, identifying clinical and biological factors that predict outcomes in patients with systemic sclerosis, and helping to discover new therapies for systemic sclerosis and interstitial lung disease. She strives to provide humanistic and compassionate care and seeks to empower her patients to improve their health through traditional, as well as holistic treatment modalities.
Thursday, November 14, 2024
4:10 PM – 4:30 PM Eastern Time
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)
Thursday, November 14, 2024
4:30 PM – 4:50 PM Eastern Time
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)
Thursday, November 14, 2024
4:50 PM – 5:10 PM Eastern Time
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)
Thursday, November 14, 2024
5:10 PM – 5:30 PM Eastern Time
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)
Sunday, November 17, 2024
2:45 PM – 3:15 PM Eastern Time
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)
Women in Scleroderma: A New Paradigm for Promoting and Sponsoring Women in Academia
Tuesday, November 19, 2024
8:15 AM – 8:35 AM Eastern Time
Disclosure(s): Boehringer-Ingelheim: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Grant/Research Support (Ongoing); Prometheus: Grant/Research Support (Ongoing)